Benzinga | Aug 4, 2020 04:31PM EDT

Apollo Endosurgery Q2 EPS $(0.30) Beats $(0.33) Estimate, Sales $5.60M Beat $5.19M Estimate

Apollo Endosurgery (NASDAQ:APEN) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.33) by 9.09 percent. This is a 25 percent increase over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $5.60 million which beat the analyst consensus estimate of $5.19 million by 7.90 percent. This is a 60.71 percent decrease over sales of $14.25 million the same period last year.